Classification
Product TypeIngredient
Product FormPowder (dry botanical extract/juice powder)
Industry PositionFood Ingredient / Dietary Supplement Ingredient
Market
Acerola extract in the United States is primarily a downstream ingredient market, used as a botanical-derived source of vitamin C in dietary supplements and in selected conventional foods positioned for “natural” or “clean-label” claims. The U.S. market is largely supplied by imported botanical ingredients, with domestic activity concentrated in formulation, blending, and finished-product manufacturing. Market access and continuity are strongly shaped by FDA regulatory expectations for identity/quality controls (dietary supplement cGMP) and by FDA import controls for human foods (Prior Notice and FSMA-related importer oversight such as FSVP, as applicable). Noncompliance can result in detention, refusal, or placement on an Import Alert (DWPE), making regulatory readiness the dominant gating factor for this product-country pair.
Market RoleImport-dependent consumer market (net importer) for acerola extract as an ingredient
Domestic RoleDownstream ingredient input for dietary supplement manufacturing and selected functional/fortified food applications in the U.S.
Market GrowthNot Mentioned
SeasonalityU.S. availability is primarily import- and inventory-driven rather than harvest-season driven at the national market level.
Specification
Primary VarietyAcerola (Malpighia emarginata DC.) fruit-derived extract/juice powder
Physical Attributes- Powdered formats are moisture-sensitive (hygroscopic) and prone to caking without appropriate drying aids and moisture-barrier packaging.
- Color and odor can vary by processing method (e.g., spray drying) and formulation (presence/absence of carriers).
Compositional Metrics- Vitamin C (ascorbic acid) assay/standardization as a commercial specification where applicable
- Moisture content / water activity controls to protect potency
- Microbiological quality limits appropriate to intended use
- Heavy metals and other contaminant testing consistent with risk profile and buyer requirements
- Residual solvent controls if solvent-based extraction is used (process-dependent)
Grades- Buyer specifications typically focus on identity confirmation and potency/assay targets rather than public commodity grades.
Packaging- Sealed, food-grade moisture-barrier inner liners within cartons/drums to limit humidity exposure during storage and distribution.
Supply Chain
Value Chain- Overseas botanical processing/extraction → international freight → U.S. customs entry with FDA oversight (as applicable) → importer/distributor warehousing → U.S. manufacturing (blending/encapsulation/food processing) → domestic distribution
Temperature- Protect from heat exposure during storage/transport to reduce degradation risk (especially for vitamin C potency).
Shelf Life- Shelf life is highly sensitive to moisture ingress and poor reclosure practices after opening; lot integrity depends on humidity control and packaging discipline.
Freight IntensityLow
Transport ModeSea
Risks
Regulatory Compliance HighShipments can be detained, refused, or placed under FDA Import Alert (DWPE) if the product appears adulterated/misbranded, if importer controls (e.g., FSVP where applicable) are deficient, or if labeling/claims position the ingredient or finished product as an unapproved drug.Align the product’s intended U.S. use (food vs dietary supplement) to the correct compliance pathway; implement documented identity and contaminant controls under cGMP; maintain complete import documentation (Prior Notice when applicable) and importer verification records; avoid disease claims in any U.S.-facing labeling/marketing materials.
Food Safety MediumBotanical ingredients can trigger enforcement or customer rejection if contaminated (e.g., microbiological hazards, heavy metals) or if the ingredient identity is not adequately verified for its intended use.Use a risk-based test plan (identity plus contaminants) and ensure supplier qualification and COA verification are documented and reproducible.
Documentation Gap MediumIf an acerola-derived ingredient is treated as a “new dietary ingredient” for dietary supplement use, lack of appropriate notification support can create an adulteration risk and commercial disruption.Perform an NDI assessment early and document the basis for status determination; submit a notification when needed and keep a defensible dossier for buyers and regulators.
Quality MediumMoisture and heat exposure can degrade potency and drive caking, leading to out-of-spec product performance and claims risk for vitamin C positioning.Specify moisture-barrier packaging, controlled storage conditions, and stability/retention testing aligned to the intended shelf life and manufacturing process.
FAQ
What are the key FDA import compliance steps if acerola extract is imported into the U.S. as a food ingredient?FDA generally expects Prior Notice before food is offered for import, and the U.S. importer may need an FSVP program to verify the foreign supplier’s controls when FSVP applies. FDA can also examine, detain, or refuse shipments that appear to violate U.S. requirements.
How does U.S. compliance differ if acerola extract is used in dietary supplements rather than conventional foods?Dietary supplements are regulated under a supplement framework (including dietary supplement cGMP in 21 CFR Part 111), while conventional foods are subject to food cGMP and preventive controls frameworks (e.g., 21 CFR Part 117, as applicable). Labeling and claims expectations also differ, and supplement marketing must avoid impermissible drug-like disease claims.
When does a New Dietary Ingredient (NDI) issue matter for acerola-derived ingredients in the U.S.?If a dietary ingredient was not marketed in the U.S. before October 15, 1994, it may be considered a New Dietary Ingredient and may require an FDA notification before being used in dietary supplements. If a required notification is not made, the product can be considered adulterated under U.S. law.